Clinical Trials Logo

Eye Diseases clinical trials

View clinical trials related to Eye Diseases.

Filter by:

NCT ID: NCT04662190 Recruiting - Clinical trials for Surgical Procedure, Unspecified

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

Start date: July 5, 2021
Phase: N/A
Study type: Interventional

This is a multicentric, randomized, single-blinded clinical trial to evaluate the efficacy and safety of 3D printing for the planification and simulation of orbital decompression surgery for thyroid-associated orbitopathy.

NCT ID: NCT04658238 Recruiting - Dry Eye Disease Clinical Trials

Ocular Microbiome and Immune System in Dry Eyes

Start date: October 1, 2020
Phase:
Study type: Observational

The primary objectives of this study are the characterization of the ocular microbiome as well as of the local immune system in participants with and without dry eye disease. Secondary objectives are the identification of differences in the ocular microbiome as well as in the immune system between participants with and without dry eye disease to ultimately find associations between the ocular microbiome and the immune system in dry eye disease.

NCT ID: NCT04548284 Recruiting - Clinical trials for Thyroid Associated Ophthalmopathy

Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO

Start date: May 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether periorbital injection of glucocorticoid is effective and necessary in the treatment of mild TAO.

NCT ID: NCT04527887 Recruiting - Dry Eye Clinical Trials

Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)

DEcIDED
Start date: September 4, 2020
Phase: Phase 4
Study type: Interventional

This prospective, single-center, randomized, double-masked, parallel comparison, sponsored study seeks to investigate the efficacy of Intracanalicular dexamethasone Insert (IDI) on ameliorating the signs and symptoms of dry eye disease.

NCT ID: NCT04519060 Recruiting - Pain Clinical Trials

Eye Shields for Infants After Dilated Exam

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The eyes of hospitalized infants are often assessed by dilated exam, and there is evidence that infants experience post-exam stress. Investigators will evaluate whether eye shields for infants after dilated eye exam lessen stress and discomfort.

NCT ID: NCT04460001 Recruiting - Ophthalmopathy Clinical Trials

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

Start date: May 16, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

To compare the clinical effectiveness of ranibizumab and combination of ranibizumab and triamcinolone for the treatment of macular oedema secondary to CRVO

NCT ID: NCT04428541 Recruiting - Eye Diseases Clinical Trials

Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children With Operable Bilateral Ocular Pathologies

EVEIL
Start date: July 16, 2020
Phase: N/A
Study type: Interventional

In some symmetrical pediatric ocular pathologies, the treatment is surgical with usually satisfactory postoperative results in visual terms. However, it is often difficult to choose the right moment to operate. The main difficulty is that the child's vision is unknown since the child is still in a preverbal age. The investigators have developed a questionnaire with the aim of quantifying the child's vision so that the decision is most justified. The items of this questionnaire were established based on the literature and were submitted to a panel of experts in ophthalmo-pediatrics. The objective of this study is to determine the internal validity and as far as possible (since there is no equivalent tool) the external validity of the questionnaire developed.

NCT ID: NCT04416776 Recruiting - Strabismus Clinical Trials

Validation of the Utility of Strabismus Intelligent Diagnostic System

Start date: September 1, 2019
Phase:
Study type: Observational

Strabismus affects approximately 0.8%-6.8% of the world's population and appears by the age of 3 years in 65% of affected individuals. Manual measurement of deviation is often laborious and highly dependent on the experience of the specialist and the cooperation of the patients. Current strabismus evaluation technologies are heavily dependent on model eyes. Here, the investigators use deep learning to develop an artificial intelligence (AI) platform consisting of three deep learning (DL) systems to screen strabismus, evaluate deviation and propose a surgical plan based on corneal light-reflection photos. The investigator also conduct clinical trial to validate its versatility in clinical practice.

NCT ID: NCT04404803 Recruiting - Eye Diseases Clinical Trials

Motivations and Barriers to Participating in Ophthalmology Research Projects

Start date: January 21, 2019
Phase:
Study type: Observational

The primary objective of this project is to understand the reasons why patients agree / disagree to take part in ophthalmology research. This will be done by asking participants to complete a Research Questionnaire.

NCT ID: NCT04359979 Recruiting - Thyroid Eye Disease Clinical Trials

Tamsulosin for Thyroid Lid Retraction

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effect of using Tamsulosin for treatment of eyelid retraction as part of thyroid eye disease. The treatment will be offered to all thyroid patients suffering from eyelid retraction who are treated at the thyroid clinic in Sheba's Ophthalmology department. All patient will receive information about the drug Tamsulosin, the possible side effects, and the alternative treatment options for retraction. Patients recruited will take 0.4mg/day Tamsulosin for 3 months and will have follow-ups at 1 week, 1 month and 3 months to evaluate the retraction status.